OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-TLR9 antibodies

Anti-TLR9 Antibody

div

Specifications Citations Related Products Product Documents
SKU Description Amount Price Availability*  
TA318603
  • Rabbit Anti-Human TLR9 Polyclonal Antibody
50ul 345 3-7 Days
Add to Shopping Cart
IHC(1)

OriGene Data

ImmunogenRecombinant protein fragment containing a sequence corresponding to a region within amino acids 26 and 300 of Human CD289(TLR9).
Clone Name IsotypeIgG
Species ReactivityHuman Concentration0.71 mg/ml
Guaranteed Application *IHC Suggested DilutionsIHC-P (5 µg/ml), WB (1:500 - 1:3000)
Buffer0.1 M Tris-glycine, pH 7, 10% Glycerol, 0.01% Thimerosal
Purification Immunoaffinity Chromatography
Note Human TLR9. Predicted cross-reactivity based on amino acid sequence homology: bovine (84%), cat (85%), dogs (83%), pig (84%), monkey (95%).

Reference Data

Target NameHomo sapiens toll-like receptor 9 (TLR9)
Alternative NameCD289
Database LinkNP_059138
Function
Related Pathway
Toll-like receptor signaling pathway

* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

IHC Image
Anti-TLR9 antibody IHC staining of human liver. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.

 

spacer
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title